1 Introduction to Research & Analysis Reports
1.1 Neurosurgery Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurosurgery Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurosurgery Drug Overall Market Size
2.1 Global Neurosurgery Drug Market Size: 2022 VS 2029
2.2 Global Neurosurgery Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Neurosurgery Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Neurosurgery Drug Players in Global Market
3.2 Top Global Neurosurgery Drug Companies Ranked by Revenue
3.3 Global Neurosurgery Drug Revenue by Companies
3.4 Global Neurosurgery Drug Sales by Companies
3.5 Global Neurosurgery Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Neurosurgery Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Neurosurgery Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neurosurgery Drug Players in Global Market
3.8.1 List of Global Tier 1 Neurosurgery Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Neurosurgery Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Neurosurgery Drug Market Size Markets, 2022 & 2029
4.1.2 Tablets
4.1.3 Solution
4.1.4 Capsules
4.1.5 Others
4.2 By Type – Global Neurosurgery Drug Revenue & Forecasts
4.2.1 By Type – Global Neurosurgery Drug Revenue, 2018-2023
4.2.2 By Type – Global Neurosurgery Drug Revenue, 2024-2029
4.2.3 By Type – Global Neurosurgery Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Neurosurgery Drug Sales & Forecasts
4.3.1 By Type – Global Neurosurgery Drug Sales, 2018-2023
4.3.2 By Type – Global Neurosurgery Drug Sales, 2024-2029
4.3.3 By Type – Global Neurosurgery Drug Sales Market Share, 2018-2029
4.4 By Type – Global Neurosurgery Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Neurosurgery Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application – Global Neurosurgery Drug Revenue & Forecasts
5.2.1 By Application – Global Neurosurgery Drug Revenue, 2018-2023
5.2.2 By Application – Global Neurosurgery Drug Revenue, 2024-2029
5.2.3 By Application – Global Neurosurgery Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Neurosurgery Drug Sales & Forecasts
5.3.1 By Application – Global Neurosurgery Drug Sales, 2018-2023
5.3.2 By Application – Global Neurosurgery Drug Sales, 2024-2029
5.3.3 By Application – Global Neurosurgery Drug Sales Market Share, 2018-2029
5.4 By Application – Global Neurosurgery Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Neurosurgery Drug Market Size, 2022 & 2029
6.2 By Region – Global Neurosurgery Drug Revenue & Forecasts
6.2.1 By Region – Global Neurosurgery Drug Revenue, 2018-2023
6.2.2 By Region – Global Neurosurgery Drug Revenue, 2024-2029
6.2.3 By Region – Global Neurosurgery Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Neurosurgery Drug Sales & Forecasts
6.3.1 By Region – Global Neurosurgery Drug Sales, 2018-2023
6.3.2 By Region – Global Neurosurgery Drug Sales, 2024-2029
6.3.3 By Region – Global Neurosurgery Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Neurosurgery Drug Revenue, 2018-2029
6.4.2 By Country – North America Neurosurgery Drug Sales, 2018-2029
6.4.3 US Neurosurgery Drug Market Size, 2018-2029
6.4.4 Canada Neurosurgery Drug Market Size, 2018-2029
6.4.5 Mexico Neurosurgery Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Neurosurgery Drug Revenue, 2018-2029
6.5.2 By Country – Europe Neurosurgery Drug Sales, 2018-2029
6.5.3 Germany Neurosurgery Drug Market Size, 2018-2029
6.5.4 France Neurosurgery Drug Market Size, 2018-2029
6.5.5 U.K. Neurosurgery Drug Market Size, 2018-2029
6.5.6 Italy Neurosurgery Drug Market Size, 2018-2029
6.5.7 Russia Neurosurgery Drug Market Size, 2018-2029
6.5.8 Nordic Countries Neurosurgery Drug Market Size, 2018-2029
6.5.9 Benelux Neurosurgery Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Neurosurgery Drug Revenue, 2018-2029
6.6.2 By Region – Asia Neurosurgery Drug Sales, 2018-2029
6.6.3 China Neurosurgery Drug Market Size, 2018-2029
6.6.4 Japan Neurosurgery Drug Market Size, 2018-2029
6.6.5 South Korea Neurosurgery Drug Market Size, 2018-2029
6.6.6 Southeast Asia Neurosurgery Drug Market Size, 2018-2029
6.6.7 India Neurosurgery Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Neurosurgery Drug Revenue, 2018-2029
6.7.2 By Country – South America Neurosurgery Drug Sales, 2018-2029
6.7.3 Brazil Neurosurgery Drug Market Size, 2018-2029
6.7.4 Argentina Neurosurgery Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Neurosurgery Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Neurosurgery Drug Sales, 2018-2029
6.8.3 Turkey Neurosurgery Drug Market Size, 2018-2029
6.8.4 Israel Neurosurgery Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Neurosurgery Drug Market Size, 2018-2029
6.8.6 UAE Neurosurgery Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Neurosurgery Drug Major Product Offerings
7.1.4 Pfizer Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Neurosurgery Drug Major Product Offerings
7.2.4 AstraZeneca Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Biogen
7.3.1 Biogen Company Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen Neurosurgery Drug Major Product Offerings
7.3.4 Biogen Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.3.5 Biogen Key News & Latest Developments
7.4 Jhonson & Jhonson
7.4.1 Jhonson & Jhonson Company Summary
7.4.2 Jhonson & Jhonson Business Overview
7.4.3 Jhonson & Jhonson Neurosurgery Drug Major Product Offerings
7.4.4 Jhonson & Jhonson Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.4.5 Jhonson & Jhonson Key News & Latest Developments
7.5 ABBVIE
7.5.1 ABBVIE Company Summary
7.5.2 ABBVIE Business Overview
7.5.3 ABBVIE Neurosurgery Drug Major Product Offerings
7.5.4 ABBVIE Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.5.5 ABBVIE Key News & Latest Developments
7.6 Takeda Pharmaceuticals
7.6.1 Takeda Pharmaceuticals Company Summary
7.6.2 Takeda Pharmaceuticals Business Overview
7.6.3 Takeda Pharmaceuticals Neurosurgery Drug Major Product Offerings
7.6.4 Takeda Pharmaceuticals Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.6.5 Takeda Pharmaceuticals Key News & Latest Developments
7.7 UCB
7.7.1 UCB Company Summary
7.7.2 UCB Business Overview
7.7.3 UCB Neurosurgery Drug Major Product Offerings
7.7.4 UCB Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.7.5 UCB Key News & Latest Developments
7.8 IPSEN
7.8.1 IPSEN Company Summary
7.8.2 IPSEN Business Overview
7.8.3 IPSEN Neurosurgery Drug Major Product Offerings
7.8.4 IPSEN Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.8.5 IPSEN Key News & Latest Developments
7.9 Standigm
7.9.1 Standigm Company Summary
7.9.2 Standigm Business Overview
7.9.3 Standigm Neurosurgery Drug Major Product Offerings
7.9.4 Standigm Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.9.5 Standigm Key News & Latest Developments
7.10 BlueStar Genomic
7.10.1 BlueStar Genomic Company Summary
7.10.2 BlueStar Genomic Business Overview
7.10.3 BlueStar Genomic Neurosurgery Drug Major Product Offerings
7.10.4 BlueStar Genomic Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.10.5 BlueStar Genomic Key News & Latest Developments
7.11 Tonix Pharmaceuticals
7.11.1 Tonix Pharmaceuticals Company Summary
7.11.2 Tonix Pharmaceuticals Neurosurgery Drug Business Overview
7.11.3 Tonix Pharmaceuticals Neurosurgery Drug Major Product Offerings
7.11.4 Tonix Pharmaceuticals Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.11.5 Tonix Pharmaceuticals Key News & Latest Developments
7.12 BlackThorn Therapeutics
7.12.1 BlackThorn Therapeutics Company Summary
7.12.2 BlackThorn Therapeutics Neurosurgery Drug Business Overview
7.12.3 BlackThorn Therapeutics Neurosurgery Drug Major Product Offerings
7.12.4 BlackThorn Therapeutics Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.12.5 BlackThorn Therapeutics Key News & Latest Developments
7.13 Quentrix
7.13.1 Quentrix Company Summary
7.13.2 Quentrix Neurosurgery Drug Business Overview
7.13.3 Quentrix Neurosurgery Drug Major Product Offerings
7.13.4 Quentrix Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.13.5 Quentrix Key News & Latest Developments
7.14 Wren Pharmaceuticals
7.14.1 Wren Pharmaceuticals Company Summary
7.14.2 Wren Pharmaceuticals Business Overview
7.14.3 Wren Pharmaceuticals Neurosurgery Drug Major Product Offerings
7.14.4 Wren Pharmaceuticals Neurosurgery Drug Sales and Revenue in Global (2018-2023)
7.14.5 Wren Pharmaceuticals Key News & Latest Developments
8 Global Neurosurgery Drug Production Capacity, Analysis
8.1 Global Neurosurgery Drug Production Capacity, 2018-2029
8.2 Neurosurgery Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Neurosurgery Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neurosurgery Drug Supply Chain Analysis
10.1 Neurosurgery Drug Industry Value Chain
10.2 Neurosurgery Drug Upstream Market
10.3 Neurosurgery Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neurosurgery Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の脳神経外科用薬剤市場予測2023-2029：錠剤、液剤、カプセル剤、その他 |
| 【英語タイトル】Neurosurgery Drug Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5805 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：75 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の脳神経外科用薬剤市場規模と予測を収録しています。・世界の脳神経外科用薬剤市場：売上、2018年-2023年、2024年-2029年 ・世界の脳神経外科用薬剤市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の脳神経外科用薬剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「錠剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 脳神経外科用薬剤のグローバル主要企業は、Pfizer、 AstraZeneca、 Biogen、 Jhonson & Jhonson、 ABBVIE、 Takeda Pharmaceuticals、 UCB、 IPSEN、 Standigm、 BlueStar Genomic、 Tonix Pharmaceuticals、 BlackThorn Therapeutics、 Quentrix、 Wren Pharmaceuticalsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、脳神経外科用薬剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の脳神経外科用薬剤市場：タイプ別、2018年-2023年、2024年-2029年 世界の脳神経外科用薬剤市場：タイプ別市場シェア、2022年 ・錠剤、液剤、カプセル剤、その他 世界の脳神経外科用薬剤市場：用途別、2018年-2023年、2024年-2029年 世界の脳神経外科用薬剤市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界の脳神経外科用薬剤市場：地域・国別、2018年-2023年、2024年-2029年 世界の脳神経外科用薬剤市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における脳神経外科用薬剤のグローバル売上、2018年-2023年 ・主要企業における脳神経外科用薬剤のグローバル売上シェア、2022年 ・主要企業における脳神経外科用薬剤のグローバル販売量、2018年-2023年 ・主要企業における脳神経外科用薬剤のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer、 AstraZeneca、 Biogen、 Jhonson & Jhonson、 ABBVIE、 Takeda Pharmaceuticals、 UCB、 IPSEN、 Standigm、 BlueStar Genomic、 Tonix Pharmaceuticals、 BlackThorn Therapeutics、 Quentrix、 Wren Pharmaceuticals ************************************************************* ・調査・分析レポートの概要 脳神経外科用薬剤市場の定義 市場セグメント 世界の脳神経外科用薬剤市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の脳神経外科用薬剤市場規模 世界の脳神経外科用薬剤市場規模：2022年 VS 2029年 世界の脳神経外科用薬剤市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの脳神経外科用薬剤の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の脳神経外科用薬剤製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：錠剤、液剤、カプセル剤、その他 脳神経外科用薬剤のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 脳神経外科用薬剤の用途別グローバル売上・予測 ・地域別市場分析 地域別脳神経外科用薬剤市場規模 2022年と2029年 地域別脳神経外科用薬剤売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer、 AstraZeneca、 Biogen、 Jhonson & Jhonson、 ABBVIE、 Takeda Pharmaceuticals、 UCB、 IPSEN、 Standigm、 BlueStar Genomic、 Tonix Pharmaceuticals、 BlackThorn Therapeutics、 Quentrix、 Wren Pharmaceuticals ... |
Neurosurgery is the surgery of the nervous system. Most of the time people think that neurosurgery is nothing but the surgery of the brain but looking deeply it is much more than that. Neurosurgery is the medical specialty that is concerned with the diagnosis of an injury or the disease that is concerned with the brain. Depending upon the patients and injury or disease doctor may choose to go for non-surgical procedures as well. There are several drugs present in the market which helps in getting relief from post neurosurgical seizures and pain. Which requires the doctor’s approval.
This report aims to provide a comprehensive presentation of the global market for Neurosurgery Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neurosurgery Drug. This report contains market size and forecasts of Neurosurgery Drug in global, including the following market information:
Global Neurosurgery Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Neurosurgery Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Neurosurgery Drug companies in 2022 (%)
The global Neurosurgery Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablets Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Neurosurgery Drug include Pfizer, AstraZeneca, Biogen, Jhonson & Jhonson, ABBVIE, Takeda Pharmaceuticals, UCB, IPSEN and Standigm, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurosurgery Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurosurgery Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurosurgery Drug Market Segment Percentages, by Type, 2022 (%)
Tablets
Solution
Capsules
Others
Global Neurosurgery Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurosurgery Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Neurosurgery Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Neurosurgery Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurosurgery Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Neurosurgery Drug revenues share in global market, 2022 (%)
Key companies Neurosurgery Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Neurosurgery Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
AstraZeneca
Biogen
Jhonson & Jhonson
ABBVIE
Takeda Pharmaceuticals
UCB
IPSEN
Standigm
BlueStar Genomic
Tonix Pharmaceuticals
BlackThorn Therapeutics
Quentrix
Wren Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Neurosurgery Drug, market overview.
Chapter 2: Global Neurosurgery Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Neurosurgery Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Neurosurgery Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Neurosurgery Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の脳神経外科用薬剤市場予測2023-2029：錠剤、液剤、カプセル剤、その他] (コード：MMG23JU5805)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の脳神経外科用薬剤市場予測2023-2029：錠剤、液剤、カプセル剤、その他]についてメールでお問い合わせ |
